| Alzheimer's
and Parkinson's disease appear to share a common thread and that may allow them
to share a common treatment in the future, according to a study reported in this
week's issue of Science. University
of Pennsylvania School of Medicine researchers discovered that alpha-synuclein
proteins found in Parkinson's disease help tau form amyloid fibers in a test tube
as well as in the brains of mice and vice versa. Tau is a protein linked to the
development of Alzheimer's disease. "Tau
and alpha-synuclein work together to promote and propagate each other's formation
of fibrous clumps and, hence, the amyloid lesions that cause disease," said
study author Benoit Gaisson, a researcher at the university's Center for Neurodegeneative
Disease Research. Researcher
Virginia Lee, PhD, who directs the university's Center for Neurodegenerative Disease
Research, said this relationship could explain why patients with one disease are
more likely to exhibit signs of the other disease. Gaisson
said a drug meant to prevent these lesions from forming in Parkinson's disease
might also help prevent tau tangles from forming in Alzheimer's disease. Other
sources: University of Pennsylvania Medical Center
|